Skip to contents
NHLBI Women's Health Initiative
Women's Health Initiative banner
 

WHI HOME

CONTACT

NHLBI POSTMENOPAUSAL HORMONE THERAPY

WHI STUDY WEBSITE

Q & As for WHI STUDY PARTICIPANTS

WHI Background and Overview

WHI Update

Why WHI?

WHI Clinical Trial / Observational Study Locations

WHI Community Prevention Study

Additional Resources

   

WHI Update

CT/OS Enrollment Status

Recruitment for the Women's Health Initiative (WHI) began in September 1993. The last participant in the CT enrolled in December 1998. The CaD trial enrolls women who are already in the HRT and/or DM trials for up to 2 years and their randomizations will continue until July 31, 2000. The OS completed enrollment on December 31, 1998.

recruitment numbers: H R T 27,348; D M  48,837; C a D 35,952;  Observational Study  93,724

Recruitment Issues

Each clinical center faced its individual challenge in recruiting participants especially for the HRT component. In some areas of the country, hormones are routinely prescribed to alleviate menopausal symptoms and thus finding eligible women to participate in the HRT was a challenging endeavor. In other areas, women are confused about the risks of taking hormones due to reports of a potential increase in breast cancer risk. The WHI will be the first clinical trial to address and answer the benefits and the potential adverse effects of HRT.


Fact Sheets

WHI Publications Reference List

NHLBI Press Releases

 
 
Department of Health and Human Services National Institutes of Health National Heart, Lung, and Blood Institute

Please send us your feedback, comments, and questions
by using the appropriate link on the page, Contact the NHLBI.

Note to users of screen readers and other assistive technologies: please report your problems here.

Link to DHHS Link to NIH Link to NHLBI Link to DHHS Link to WHI Home